Friday, October 16, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Ams Osram Closes €570m Infineon Sale, Sets Sights on €40m Interest Savings and 2027 Free Cash Flow Turnaround

Rodolfo Hanigan by Rodolfo Hanigan
July 12, 2026
in Analysis, Mergers & Acquisitions, Semiconductors, TecDAX
0
Ams Osram Stock
0
SHARES
85
VIEWS
Share on FacebookShare on Twitter

Ams Osram has finalized the disposal of its non‑optical analog and mixed‑signal sensor business to Infineon, pocketing €570m in cash that will be channeled straight into debt reduction. The transaction, first announced in February 2026 and cleared by all regulatory bodies, closed on 1 July. Around 230 employees from research, development and management now move to Infineon, which expects the acquired unit to contribute roughly €230m in revenue in 2026 and to be immediately accretive to its earnings per share.

Yet the market greeted the milestone with a yawn. Ams Osram’s stock slipped 3.32% on Friday to close at €20.40, leaving it with a weekly loss of 5.99% and a month‑to‑date gain of 18.26%. The deal’s completion is the centrepiece of a broader deleveraging campaign that also includes the refinancing of senior notes in May and June. Together, these steps are expected to slash annual interest expenses by around €40m. Chief Executive Aldo Kamper has set a clear medium‑term target: the company aims to generate positive free cash flow for the first time since its restructuring drive by 2027, and analysts see positive earnings per share arriving no earlier than that year.

Rating agencies remain cautious, however. Fitch calculates that Ams Osram’s EBITDA leverage at the end of 2025 was higher than the pro‑forma ratio communicated by management, suggesting the balance‑sheet cleanup still has some way to go. The €570m infusion will help, but the market appears to be pricing in a long slog rather than a quick fix.

Should investors sell immediately? Or is it worth buying Ams Osram?

The valuation picture is equally muddled. Analyst price targets diverge dramatically. Data from Fintel show a mean one‑year target of CHF 10.98, with a range spanning CHF 7.14 to CHF 15.54 — all well below current levels. Cash.ch reports a similar average of CHF 15.50. In stark contrast, a discounted cash‑flow model by Simply Wall St, cited by Yahoo Finance, pegs fair value at CHF 49.36, roughly 2.7 times the CHF 18.35 share price at the time of the analysis. Whether those cash‑flow projections are attainable for a company still posting losses and unlikely to turn profitable within three years is an open question. On a conventional price‑to‑sales basis, Ams Osram trades at 0.6x trailing revenue of €3.299bn (market cap: €2.12bn), versus the sector median of 4.8x — a gap that could signal either deep undervaluation or structural concerns.

Technically, the stock is hovering near its 50‑day moving average of €20.20, with the relative strength index at 51.6 — a neutral reading that suggests neither overbought nor oversold conditions. The 200‑day average stands at €12.39, meaning the current price is 64.63% above that level, a testament to the extraordinary rally from December’s 52‑week low of €7.38. Still, the share is 23.6% below the 52‑week high of €26.70 set on 26 May 2026, and the annualized 30‑day volatility of almost 99% underscores how violently the stock can swing.

For the weeks ahead, investors will weigh two cross‑currents: the concrete interest savings and portfolio focus from the Infineon deal, and the stubbornly wide gap between the most optimistic and most pessimistic views on the company’s intrinsic worth. The first major checkpoint remains the 2027 free‑cash‑flow milestone — a test that will ultimately separate the bullish narrative from the cautionary one.

Ad

Ams Osram Stock: Buy or Sell?! New Ams Osram Analysis from October 15 delivers the answer:

The latest Ams Osram figures speak for themselves: Urgent action needed for Ams Osram investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 15.

Ams Osram: Buy or sell? Read more here...

Tags: Ams Osram
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Next Post
Xiaomi Stock

Xiaomi Battles a Two-Year Memory Cost Squeeze Even as Its SUV Ambitions Grow

TKMS Stock

TKMS: The €62 Billion Question the Market Is Asking — and the Answer So Far Is ‘Wait’

Bayer Stock

Bayer Juggles a €3B Capital Injection with a Sweeping Legal Bid, Even as Farmers Turn on the Ag Giant

Recommended

CRA Stock

CRA International Gains Momentum with Strategic Hires and Upgraded Outlook

1 year ago
Standard Lithium Stock

A Billion-Dollar Vote of Confidence for Standard Lithium

10 months ago
Quantum eMotion Stock

Quantum eMotion’s High-Stakes Summer: CEO Options, a UN Stage, and the Revenue Conversion Test

4 months ago
VCIT stock news

Muzinich & Co. Inc. Decreases Stake in Oaktree Specialty Lending Co.: A Shift in Investment Strategy

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Optics Run Hot as Chip Leaders Pause for Breath

SpaceX Hits the Carriers, Medicare Stars Lift Humana

OpenAI’s Miss Exposes AI’s Debt Load as Yields Climb

Banks Slump 13% Ahead of Profit Gains of Up to 20%

Records on Narrow Shoulders as the 10-Year Yield Tops 5.3%

PepsiCo and Delta Put the US Consumer to the Test as Stocks Hit Records

Trending

CoreWeave Stock
Newsletter

CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat

by Stephanie Dugan
October 15, 2026
0

Dear readers, Yesterday's question was who has the pricing power to defend a valuation. Today's is harder:...

ASML Holding Stock

Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles

October 14, 2026
OpenAI Stock

Goldman Delivers as Memory Stocks Slide Ahead of CPI

October 13, 2026
Lumentum Stock

Optics Run Hot as Chip Leaders Pause for Breath

October 12, 2026
Humana Stock

SpaceX Hits the Carriers, Medicare Stars Lift Humana

October 10, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CoreWeave’s Bonds Flash Red as Strong Earnings Fall Flat
  • Hot Core CPI Sorts the Stocks: ASML Delivers, J&J Stumbles
  • Goldman Delivers as Memory Stocks Slide Ahead of CPI

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com